IBDEI04Q ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6044,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,6044,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,6045,0)
 ;;=237.70^^36^397^66
 ;;^UTILITY(U,$J,358.3,6045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6045,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,6045,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,6045,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,6046,0)
 ;;=239.6^^36^397^65
 ;;^UTILITY(U,$J,358.3,6046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6046,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,6046,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,6046,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,6047,0)
 ;;=239.81^^36^397^97
 ;;^UTILITY(U,$J,358.3,6047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6047,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,6047,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,6047,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,6048,0)
 ;;=272.0^^36^397^48
 ;;^UTILITY(U,$J,358.3,6048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6048,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,6048,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,6048,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,6049,0)
 ;;=340.^^36^397^63
 ;;^UTILITY(U,$J,358.3,6049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6049,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,6049,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,6049,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,6050,0)
 ;;=345.90^^36^397^29
 ;;^UTILITY(U,$J,358.3,6050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6050,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,6050,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,6050,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,6051,0)
 ;;=368.02^^36^397^23
 ;;^UTILITY(U,$J,358.3,6051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6051,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,6051,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,6051,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,6052,0)
 ;;=368.11^^36^397^103
 ;;^UTILITY(U,$J,358.3,6052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6052,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,6052,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,6052,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,6053,0)
 ;;=368.59^^36^397^11
 ;;^UTILITY(U,$J,358.3,6053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6053,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,6053,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,6053,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,6054,0)
 ;;=368.60^^36^397^67
 ;;^UTILITY(U,$J,358.3,6054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6054,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,6054,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,6054,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,6055,0)
 ;;=368.9^^36^397^114
 ;;^UTILITY(U,$J,358.3,6055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6055,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6055,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,6055,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,6056,0)
 ;;=369.00^^36^397^109
 ;;^UTILITY(U,$J,358.3,6056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6056,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,6056,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,6056,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,6057,0)
 ;;=369.01^^36^397^110
 ;;^UTILITY(U,$J,358.3,6057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6057,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,6057,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,6057,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,6058,0)
 ;;=369.02^^36^397^75
 ;;^UTILITY(U,$J,358.3,6058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6058,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,6058,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,6058,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,6059,0)
 ;;=369.03^^36^397^74
 ;;^UTILITY(U,$J,358.3,6059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6059,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,6059,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,6059,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,6060,0)
 ;;=369.04^^36^397^64
 ;;^UTILITY(U,$J,358.3,6060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6060,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,6060,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,6060,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,6061,0)
 ;;=369.06^^36^397^78
 ;;^UTILITY(U,$J,358.3,6061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6061,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,6061,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,6061,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,6062,0)
 ;;=369.07^^36^397^77
 ;;^UTILITY(U,$J,358.3,6062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6062,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,6062,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,6062,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,6063,0)
 ;;=369.08^^36^397^92
 ;;^UTILITY(U,$J,358.3,6063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6063,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,6063,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,6063,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,6064,0)
 ;;=369.10^^36^397^73
 ;;^UTILITY(U,$J,358.3,6064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6064,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,6064,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,6064,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,6065,0)
 ;;=369.11^^36^397^79
 ;;^UTILITY(U,$J,358.3,6065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6065,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,6065,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,6065,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,6066,0)
 ;;=369.12^^36^397^82
 ;;^UTILITY(U,$J,358.3,6066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6066,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,6066,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,6066,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,6067,0)
 ;;=369.13^^36^397^80
 ;;^UTILITY(U,$J,358.3,6067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6067,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,6067,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,6067,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,6068,0)
 ;;=369.14^^36^397^81
 ;;^UTILITY(U,$J,358.3,6068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6068,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,6068,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,6068,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,6069,0)
 ;;=369.22^^36^397^102
 ;;^UTILITY(U,$J,358.3,6069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6069,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,6069,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,6069,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,6070,0)
 ;;=369.60^^36^397^6
 ;;^UTILITY(U,$J,358.3,6070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6070,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,6070,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,6070,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,6071,0)
 ;;=369.9^^36^397^115
 ;;^UTILITY(U,$J,358.3,6071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6071,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,6071,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,6071,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,6072,0)
 ;;=377.61^^36^397^20
 ;;^UTILITY(U,$J,358.3,6072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6072,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,6072,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,6072,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,6073,0)
 ;;=379.02^^36^397^68
 ;;^UTILITY(U,$J,358.3,6073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6073,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,6073,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,6073,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,6074,0)
 ;;=379.07^^36^397^90
 ;;^UTILITY(U,$J,358.3,6074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6074,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,6074,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,6074,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,6075,0)
 ;;=379.92^^36^397^106
 ;;^UTILITY(U,$J,358.3,6075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6075,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,6075,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,6075,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,6076,0)
 ;;=379.93^^36^397^94
 ;;^UTILITY(U,$J,358.3,6076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6076,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,6076,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,6076,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,6077,0)
 ;;=379.99^^36^397^86
 ;;^UTILITY(U,$J,358.3,6077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6077,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,6077,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,6077,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,6078,0)
 ;;=555.9^^36^397^95
 ;;^UTILITY(U,$J,358.3,6078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6078,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,6078,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,6078,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,6079,0)
 ;;=696.1^^36^397^93
 ;;^UTILITY(U,$J,358.3,6079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6079,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,6079,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,6079,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,6080,0)
 ;;=709.2^^36^397^39
 ;;^UTILITY(U,$J,358.3,6080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6080,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,6080,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,6080,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,6081,0)
 ;;=710.0^^36^397^60
 ;;^UTILITY(U,$J,358.3,6081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6081,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,6081,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,6081,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,6082,0)
 ;;=710.9^^36^397^10
 ;;^UTILITY(U,$J,358.3,6082,1,0)
 ;;=^358.31IA^4^2
